Full Name
Chan Wing Yuen,Eli
(not current staff)
Variants
Chan, E.W.Y.
Chan, E.
Chan, E.W.
Chan, W.Y.
 
Main Affiliation
 
Faculty
 
Email
phaelic@nus.edu.sg
 

Publications

Results 41-60 of 85 (Search time: 0.005 seconds).

Issue DateTitleAuthor(s)
411-Dec-2007Is a standard fixed dose of mycophenolate mofetil ideal for all patients?Yau, Wai-Ping ; Vathsala, Anantharaman ; Lou, Huei-Xin; Chan, Eli 
42Jun-1997Lithium pharmacokinetics in Chinese manic-depressive patientsWing, Y.-K.; Chan, E. ; Chan, K.; Lee, S.; Shek, C.C.
43Feb-2012Loading 3-deazaneplanocin A into pegylated unilamellar liposomes by forming transient phenylboronic acid-drug complex and its pharmacokinetic features in Sprague-Dawley ratsSun, F. ; Li, J.; Yu, Q.; Chan, E. 
41-Jun-2009Mechanism-Based Enterohepatic Circulation Model of Mycophenolic Acid and Its Glucuronide Metabolite: Assessment of Impact of Cyclosporine Dose in Asian Renal Transplant PatientsYau, Wai-Ping ; Vathsala, Anantharaman ; Lou, Huei-Xin; Zhou, Shufeng; Chan, Eli 
52005Mechanism-based inhibition of cytochrome P450 3A4 by therapeutic drugsZhou, S. ; Chan, S.Y. ; Goh, B.C. ; Chan, E. ; Duan, W. ; Huang, M.; McLeod, H.L.
6Jan-2005Multidrug resistance proteins (MRPs) and implication in drug developmentTian, Q. ; Zhang, J.; Chan, E. ; Duan, W.; Zhou, S. 
72005Novel agents that potentially inhibit irinotecan-induced diarrheaYang, X. ; Hu, Z.; Chan, S.Y. ; Chan, E. ; Goh, B.C. ; Duan, W.; Zhou, S. 
8May-2006Pharmacokinetic mechanisms for reduced toxicity of irinotecan by coadministered thalidomideYang, X.-X.; Hu, Z.-P.; Chan, S.Y. ; Duan, W.; Ho, P.C.-L. ; Boelsterli, U.A.; Ng, K.-Y. ; Chan, E. ; Bian, J.-S.; Chen, Y.-Z. ; Huang, M.; Zhou, S.-F. 
9Aug-2006Pharmacokinetics of recombinant human endostatin in ratsYang, X.-X.; Hu, Z.-P.; Chan, E. ; Duan, W.; Zhou, S. 
102001Population pharmacokinetics of carbamazepine in Singapore epileptic patientsChan, E. ; Lee, H.S. ; Hue, S.S.
112001Population pharmacokinetics of carbamazepine in Singapore epileptic patientsChan, E. ; Lee, H.S.; Hue, S.S.
12Aug-1990Population pharmacokinetics of phenytoin in Singapore ChineseChan, E. ; Ti, T.Y.; Lee, H.S.
132004Predicting pharmacokinetic herb-drug interactionsZhou, S. ; Chan, E. ; Li, S.C. ; Huang, M.; Chen, X.; Li, X.; Zhang, Q.; Paxton, J.W.
14Sep-2009Prediction of deleterious non-synonymous single-nucleotide polymorphisms of human uridine diphosphate glucuronosyltransferase genesDi, Y.M.; Chan, E. ; Wei, M.Q.; Liu, J.-P.; Zhou, S.-F.
152005Protective effect of Ganoderma (a mushroom with medicinal properties) against various liver injuriesGao, Y.; Gao, H.; Chan, E. ; Tang, W.; Li, X.; Liang, J.; Zhou, S. 
161-Feb-2011Quantification of 3-deazaneplanocin A, a novel epigenetic anticancer agent, in rat biosamples by hydrophilic interaction liquid chromatography-tandem mass spectrometric detectionSun, F. ; Ong, J.C.L.; Yu, Q.; Chan, E. 
17May-2006Relationship between genotype and enzyme activity of glutathione S-transferases M1 and P1 in ChineseZhong, S.-L.; Zhou, S.-F. ; Chen, X.; Chan, S.Y. ; Chan, E. ; Ng, K.-Y. ; Duan, W.; Huang, M.
18Oct-2006Relationship of glutathione S-transferase genotypes with side-effects of pulsed cyclophosphamide therapy in patients with systemic lupus erythematosusZhong, S.; Huang, M.; Yang, X.; Liang, L.; Wang, Y.; Romkes, M.; Duan, W.; Chan, E. ; Zhou, S.-F. 
19Feb-1994Renal handling of warfarin metabolites in manChan, E. ; McLachlan, A.J.; Rowland, M.
2025-Jan-2004Reversed-phase liquid chromatography method to determine COL-3, a matrix metalloproteinase inhibitor, in biological samplesLi, J.; Huynh, H.; Chan, E.